Pay in 4 interest-free payments of $5.00 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
How to Talk to Your Doctor About GLP-1 Weight Loss Drugs Chronic Diseases That GLP-1s Are FDA-Approved to Treat GLP-1s for Heart Disease In March 2024, the FDA approved the GLP-1 drug Wegovy (semaglutide) to treat heart disease in people who are overweight or who have obesity the first approval for a GLP-1 medication outside of diabetes or weight loss
Acknowledgements This study/project was funded by the NIHR Invention for Innovation programme (grant number NIHR200022)
Jahangard, Leila, et al
Informacin molecular Frmula molecular: C 14 H 22 N 4 O 9 Peso molecular: X Nmero CAS: 307297-39-8 Aplicaciones de investigacin Estudios de interaccin pptido-receptor Investigaciones sobre las vas de sealizacin celular Investigacin de procesos bioqumicos Investigaciones que involucran anlogos de pptidos sintticos Descargo de responsabilidad: Solo para uso en investigacin de laboratorio
A: Not officiallythey are approved for Type 2 diabetes and weight management
